Artivion (AORT) Free Cash Flow (2010 - 2026)
Artivion (AORT) posted Free Cash Flow of -$6.8 million for Q1 2026, up 13.82% on a QoQ basis from -$7.9 million in Q4 2025, and up 66.74% year-over-year from -$4.1 million in Q1 2025.
Artivion (AORT) Free Cash Flow (2010 - 2026) Analysis & Trends
Artivion's Free Cash Flow history runs 17 years deep, the most recent figure standing at -$6.8 million for Q1 2026.
- Quarterly Free Cash Flow rose 66.74% year-over-year to -$6.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.6 million (up 3421.41% YoY) and the FY2025 annual result came in at $839000.0, down 92.41% from the prior year.
- Free Cash Flow was -$6.8 million for Q1 2026 at Artivion, up from -$7.9 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $17.7 million in Q3 2025 and bottomed at -$20.6 million in Q1 2025.
- A 5-year average of -$103352.9 and a median of $1.1 million in 2022 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2022 — Free Cash Flow sank 226.77% — and 2023, when it soared 366.49%.
- Artivion's Free Cash Flow stood at -$4.0 million in 2022, then jumped by 303.82% to $8.2 million in 2023, then advanced by 6.67% to $8.7 million in 2024, then plunged by 191.2% to -$7.9 million in 2025, then climbed by 13.82% to -$6.8 million in 2026.
- Business Quant data shows AORT's Free Cash Flow at -$6.8 million in Q1 2026, -$7.9 million in Q4 2025, and $17.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 449.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 305.56 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 112.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Artivion | 1.25 Bn | 1.19 Bn | 75.45 Mn | -6.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.85 Mn |
| Mar 31, 2026 | -6.85 Mn |
| Dec 31, 2025 | -7.95 Mn |
| Dec 31, 2025 | -7.95 Mn |
| Sep 30, 2025 | 17.65 Mn |
| Sep 30, 2025 | 17.65 Mn |
| Jun 30, 2025 | 11.72 Mn |
| Jun 30, 2025 | 11.72 Mn |
| Mar 31, 2025 | -20.59 Mn |
| Mar 31, 2025 | -20.59 Mn |
| Dec 31, 2024 | 8.71 Mn |
| Dec 31, 2024 | 8.71 Mn |
| Sep 30, 2024 | 7.82 Mn |
| Sep 30, 2024 | 7.82 Mn |
| Jun 30, 2024 | 3.62 Mn |
| Jun 30, 2024 | 3.62 Mn |
| Mar 31, 2024 | -9.10 Mn |
| Mar 31, 2024 | -9.10 Mn |
| Dec 31, 2023 | 8.17 Mn |
| Dec 31, 2023 | 8.17 Mn |